Genome-wide analysis of genes related to kidney stone formation and elimination in the calcium oxalate nephrolithiasis model mouse: Detection of stone-preventive factors and involvement of macrophage activity

Journal of Bone and Mineral Research

Volumn 24, Issue 5, 2009, Pages 908-924

  Okada, Atsushi ^a   Yasui, Takahiro ^a   Hamamoto, Shuzo ^a   Hirose, Masahito ^a   Kubota, Yasue ^a   Itoh, Yasunori ^a   Tozawa, Keiichi ^a   Hayashi, Yutaro ^a   Kohri, Kenjiro ^a  

^a NAGOYA CITY UNIVERSITY GRADUATE SCHOOL OF MEDICAL SCIENCES   (Japan)

Author keywords

Calcium oxalate; Glyoxylate; Kidney stone model mouse; Macrophage; Microarray

Indexed keywords

CHEMOKINE; GLYOXYLIC ACID; MATRIX PROTEIN; MESSENGER RNA; SUPEROXIDE DISMUTASE; TAMM HORSFALL GLYCOPROTEIN; TRANSCRIPTOME;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CALCIUM OXALATE STONE; CHEMOTAXIS; COMPLEMENT ACTIVATION; CONTROLLED STUDY; GENE EXPRESSION; GENE FUNCTION; GENE IDENTIFICATION; GENE OVEREXPRESSION; IMMUNITY; INFLAMMATION; MACROPHAGE ACTIVATION; MACROPHAGE MIGRATION; MALE; MICROARRAY ANALYSIS; MONOCYTE; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PROTEIN EXPRESSION; UNINDEXED SEQUENCE;

ANIMALS; CALCIUM OXALATE; DISEASE MODELS, ANIMAL; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENOME-WIDE ASSOCIATION STUDY; IMMUNOHISTOCHEMISTRY; KIDNEY CALCULI; MACROPHAGES; MICE; MICE, INBRED C57BL; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS;

EID: 65949123766     PISSN: 08840431     EISSN: None     Source Type: Journal    
DOI: 10.1359/jbmr.081245     Document Type: Article

References (50)

1. Rodgers AL, De Klerk DP 1986 Crystalluria and urolithiasis in a relatively stone-free population. Scan Electron Microsc 3:1157-1167.
2. Asplin JR, Parks JH, Coe FL 1997 Dependence of upper limit of metastability on supersaturation in nephrolithiasis. Kidney Int 52:1602-1608.
3. Khan SR 1995 Calcium oxalate crystal interaction with renal tubular epithelium, mechanism of crystal adhesion and its impact on stone development. Urol Res 23:71-79.
4. Finlayson B, Reid F 1978 The effect of allopurinol on calcium oxalate (whewellite) precipitation. Invest Urol 15:489-492.
5. Kohri K, Suzuki Y, Yoshida K, Yamamoto K, Amasaki N, Yamate T, Umekawa T, Iguchi M, Sinohara H, Kurita T 1992 Molecular cloning and sequencing of cDNA encoding urinary stone protein, which is identical to osteopontin. Biochern Bi ophys Res Commun 184:859-864.
6. Umekawa T, Yamate T, Amasaki N, Kohri K, Kurita T 1995 Osteopontin mRNA in the kidney on an experimental rat model of renal stone formation without renal failure. Urol Int 55:6-10.
7. Tawada T, Fujita K, Sakakura T, Shibutani T, Nagata T, Iguchi M, Kohri K 1999 Distribution of osteopontin and calprotectin as matrix protein in calcium-containing stone. Urol Res 27:238-242.
8. Yasui T, Fujita K, Asai K, Kohri K 2002 Osteopontin regulates adhesion of calcium oxalate crystals to renal epithelial cells. Int J Urol 9:100-108.
9. Yamate T, Kohri K, Umekawa T, Iguchi M, Kurita T 1998 Osteopontin antisense oligonucleotide inhibits adhesion of calcium oxalate crystals in Madin-Darby canine kidney cell. J Urol 160:1506-1512.
10. Okada A, Nomura S, Saeki Y, Higashibata Y, Hamamoto S, Hirose M, Itoh Y, Yasui T, Tozawa K, Kohri K 2008 Mor phological conversion of calcium oxalate crystals into stones is regulated by osteopontin in mouse kidney. J Bone Miner Res 23:1629-1637.
11. Gao B, Yasui T, Itoh Y, Li Z, Okada A, Tozawa K, Hayashi Y, Kohri K 2007 Association of osteopontin gene haplotypes with nephrolithiasis. Kidney Int 72:592-598.
12. Hunter GK, Kyle CL, Goldberg HA 1994 Modulation of crystal formation by bone phosphoproteins: Structural speci ficity of the osteopontin-mediated inhibition of hydroxyappatite formation. Biochem J 300:723-728.
13. Asplin JR, Arsenault D, Parks JH, Coe FL, Hoyer JR 1998 Contribution of human uropontin to inhibition of calcium oxalate crystallization. Kidney Int 53:194-199.
14. Wesson JA, Johnson RJ, Mazzali M, Beshensky AM, Stietz S, Giachelli C 2003 Osteopontin is a critical inhibitor of calcium oxalate crystal formation and retention in renal tubules. J Am Soc Nephrol 14:139-147.
15. Umekawa T, Chegini N, Khan SR 2002 Oxalate ions and calcium oxalate crystals stimulate MCP-1 expression by renal epithelial cells. Kidney Int 61:105-112.
16. Verhulst A, Asselman M, Persy VP, Schepers MS, Helbert MF, Verkoelen CF, De Broe ME 2003 Crystal retention ca pacity of cells in the human nephron: Involvement of CD44 and its ligands hyaluronic acid and osteopontin in the transi tion of a crystal binding-into a nonadherent epithelium. J Am Soc Nephrol 14:107-115.
17. Ghazali A, Fuent V, Desaint C, Bataille P, Westeel A, Brazier M, Prin L, Fournier A 1997 Low bone mineral density and peripheral blood monocyte activation profile in calcium stone formers with idiopathic hypercalciuria. J Clin Endocrinol Metab 82:32-38.
18. Tsujihata M, Miyake O, Yoshimura K, Kakimoto K, Takahara S, Okuyama A 2001 Comparison of fibronectin content in urinary macromolecules between normal subjects and recur rent stone formers. Eur Urol 40:458-462.
19. Cramer SD, Ferree PM, Lin K, Milliner DS, Holmes RP 1999 The gene encoding hydroxypyruvate reductase (GRHPR) is mutated in patients with primary hyperoxaluria type II. Hum Mol Genet 8:2063-2069.
20. Kohjimoto Y, Honeyman TW, Jonassen J, Gravel K, Kennington L, Scheid CR 2000 Phospholipase A2 mediates immediate early genes in cultured renal epithelial cells: Possible role of lysophospholipid. Kidney Int 58:638-646.
21. Urivetsky M, Motola J, King L, Smith AD 1989 Impact of percutaneous renal stone removal on renal function: Assess ment by urinary lysozyme activity. Urology 33:305-308.
22. Yasui T, Fujita K, Sasaki S, Sato M, Sugimoto M, Hirota S, Kitamura Y, Nomura S, Kohri K 1999 Abstract expression of bone matrix proteins in urolithiasis model rats. Urol Res 27:255-261.
23. Miyazawa K, Suzuki K, Ikeda R, Moriyama MT, Ueda Y, Katsuda S 2005 Apoptosis and its related genes in renal epi thelial cells of the stone-forming rat. Urol Res 33:31-38.
24. Graessler J, Graessler A, Unger S, Kopprasch S, Tausche AK, Kuhlisch E, Schroeder HE 2006 Association of the human urate transporter 1 with reduced renal uric acid excretion and hyperuricemia in a German Caucasian population. Arthritis Rheum 54:292-300.
25. Tzortzaki EG, Yang M, Glass D, Deng L, Evan AP. Bledsoe SB, Stambrook PJ, Sahota A, Tischfield JA 2003 Impaired expres sion of an organic cation transporter, IMPT1, in a knockout mouse model for kidney stone disease. Urol Res 31:257-261.
26. Prie D, Huart V, Bakouh N, Planelles G, Dellis O, Gerard B, Hulin P, Benque-Blanchet F, Silve C, Grandcham B, Fried lander G 2002 Nephrolithiasis and osteoporosis associated with hypophosphatemia caused by mutations in the type 2a sodium-phosphate cotransporter. N Engl J Med 347:983-991.
27. Tugcu V, Ozbek E, Aras B, Arisan S, Caskurlu T, Tasci AI 2007 Manganese superoxide dismutase (Mn-SOD) gene pol ymorphisms in urolithiasis. Urol Res 35:219-224.
28. Rashed T, Menon M, Thamilselvan S 2004 Molecular mech anism of oxalate-induced free radical production and gluta thione redox imbalance in renal epithelial cells: Effect of antioxidants. Am J Nephrol 24:557-568.
29. Katsuma S, Shiojima S, Hirasawa A, Takagaki K, Kaminishi Y, Koba M. Hagidai Y, Murai M, Ohgi T, Yano J, Tsujimoto G 2002 Global analysis of differentially expressed genes during progression of calcium oxalate nephrolithiasis. Biochem Biophys Res Commun 23:544-552.
30. Chen DH, Kaung HL, Miller CM, Resnick MI, Marengo SR 2004 Microarray analysis of changes in renal phenotype in the ethylene glycol rat model of urolithiasis: Potential and pitfalls. BJU Int 94:637-650.
31. Hoopes RR Jr, Middleton FA, Sen S, Hueber PA, Reid R, Bushinsky DA, Scheinman SJ 2006 Isolation and confirmation of a calcium excretion quantitative trait locus on chromo some 1 in genetic hypercalciuric stone-forming congenic rats. J Am Soc Nephrol 17:1292-1304.
32. Liang L, Chen J, Vittal R, Selvanayagam ZE, McAteer JA, Deng L, Tischfield J, Chin KV, Sahota A 2006 Expression profiling of crystal-induced injury in human kidney epithelial cells. Nephron, Physiol 103:53-62.
33. Okada A, Nomura S, Saeki Y, Higashibata Y, Hirose M, Gao B, Yoshimura M, Itoh Y, Yasui T, Tozawa K, Kohri K 2007 Suc cessful formation of calcium oxalate stone in mouse kidney by the injection of glyoxylate intraperitoneally. Urol Res 35:89-99.
34. Hirose M, Tozawa K, Okada A, Hamamoto S, Shimizu H, Kubota Y, Itoh Y, Yasui T, Kohri K 2008 Glyoxylate induces renal tubular cell injury and microstructural changes in ex perimental mouse. Urol Res 36:139-147.
35. Pizzolato P 1964 Histochemical recognition of calcium oxa late. J Histochem Cytochem 12:333-336.
36. Itoh Y, Yasui T, Okada A, Tozawa K, Hayashi Y, Kohri K 2005 Examination of the anti-oxidative effect in renal tubular cells and apoptosis by oxidative stress. Urol Res 33:261-266.
37. Itoh Y, Yasui T, Okada A, Tozawa K, Hayashi Y, Kohri K 2005 Preventive effects of green tea on renal stone formation and the role of oxidative stress in nephrolithiasis. J Urol 173:271-275.
38. Nunn AV, Bell J, Barter P 2007 The integration of lipid sensing and anti-inflammatory effects: How the PPARs play a role in metabolic balance. Nucl Recept 25:1.
39. Kim JY, Lee KJ, Kim DH, Jeong TC, Lee ES, Choi YM, Jeong HG 2004 Cytokine-mediated induction of metallothionein in Hepa-lclc7 cells by oleanolic acid. Biochem Biophys Res Commun 325:792-797.
40. Miller CW, Ntambi JM 1996 Peroxisome proliferators induce mouse liver stearoyl-CoA desaturase 1 gene expression. Proc Natl Acad Sci USA 93:9443-9448.
41. Mo L, Huang HY. Zhu XH, Shapiro E, Hasty DL, Wu XR 2004 Tamm-Horsfall protein is a critical renal defense factor protecting against calcium oxalate crystal formation. Kidney Int 66:1159-1166.
42. de Water R, Noordermeer C, van der Kwast TH, Nizze H, Boeve ER, Kok DJ, Schroder FH 1999 Calcium oxalate nephrolithiasis: Effect of renal crystal deposition on the cel lular composition of the renal interstitium. Am J Kidney Dis 33:761-771.
43. Khan SR, Thamilselvan S 2000 Nephrolithiasis: A conse quence of renal epithelial cell exposure to oxalate and calcium oxalate crystals. Mol Urol 4:305-312.
44. De Water R, Noordermeer C, Houtsmuller AB, Nigg AL, Stijnen T, Schroder FH, Kok DJ 2000 Role of macrophages in nephrolithiasis in rats: An analysis of the renal interstitium. Am J Kidney Dis 36:615-625.
45. Burdo TH, Wood MR, Fox HS 2007 Osteopontin prevents monocyte recirculation and apoptosis. J Leukoc Biol 81:1504-1511.
46. Ryall RL, Chauvet MC, Grover PK 2005 Intracrystalline proteins and urolithiasis: A comparison of the protein content and ultrastructure of urinary calcium oxalate monohydrate and dihydrate crystals. BJU Int 96:654-663.
47. der Wal AC, Das PK, Tigges AJ, Becker AE 1992 Macro phage differentiation in atherosclerosis. An in situ immuno histochemical analysis in humans. Am J Pathol 141:161-168.
48. Dyerberg J, Bang HO, Hjorne N 1975 Fatty acid composition of the plasma lipids in Greenland Eskimos. Am J Clin Nutr 28:958-966.
49. Yasui T, Itoh Y, Bing G, Okada A, Tozawa K, Kohri K 2007 Aortic calcification in urolithiasis patients. Scand J Urol Nephrol 41:419-421.
50. Yasui T, Tanaka H, Fujita K, Iguchi M, Kohri K 2001 Effects of eicosapentaenoic acid on urinary calcium excretion in calcium stone formers. Eur Urol 39:580-585.